Literature DB >> 28330820

Analysis of the Association Between Electrocardiographic P-wave Characteristics and Atrial Fibrillation in the REGICOR Study.

Albert Massó-van Roessel1, Luis Alberto Escobar-Robledo1, Irene R Dégano2, María Grau2, Joan Sala3, Rafel Ramos4, Jaume Marrugat2, Antoni Bayés de Luna1, Roberto Elosua5.   

Abstract

INTRODUCTION AND
OBJECTIVES: Atrial fibrillation (AF) is the most common clinically significant cardiac arrhythmia. P-wave duration and interatrial blocks (IAB) have been reported to be associated with AF. Our aim was to determine the individual and combined association of P-wave duration and advanced IAB morphology with AF.
METHODS: We designed an age-, sex-, and survey-matched case-control study nested in a population-based cohort (REGICOR: REgistre GIroní del COR). Two different surveys recruited a total of 9380 participants from 1999 to 2005; all participants were invited to a second examination between 2009 and 2013. For the present study, we selected participants aged 25 to 79 years with follow-up through the end of the study. All electrocardiograms were analyzed by 2 observers to determine P-wave duration and morphology (normal, partial, or advanced IAB).
RESULTS: The median follow-up was 7.12 years. Eighty participants presented with AF, had a legible baseline electrocardiogram, and were included in the study, along with 160 controls. P-wave duration and the presence of partial or advanced IAB were associated with AF. When P-wave duration and morphology were considered together, only P-wave duration (≥ 110 milliseconds) showed an independent and strong association with AF. The odds ratio for AF of P-wave duration between 110-119, 120-129 and ≥ 130 milliseconds vs < 110 milliseconds were 5.33; 95%CI, 1.74-16.33, 5.08; 95%CI, 1.73-14.90 and 5.44; 95%CI, 1.95-15.15, respectively.
CONCLUSIONS: A P-wave longer than 110 milliseconds increases the risk of AF. Advanced IAB morphology did not seem to provide an additional AF risk beyond that of P-wave duration.
Copyright © 2017 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Bloqueo interauricular; Duración de la onda P; Fibrilación auricular; Interatrial blocks; P-wave duration

Mesh:

Year:  2017        PMID: 28330820     DOI: 10.1016/j.rec.2017.02.019

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  4 in total

1.  The prevalence and prognostic significance of interatrial block in the general population.

Authors:  Tiia Istolahti; Antti Eranti; Heini Huhtala; Leo-Pekka Lyytikäinen; Mika Kähönen; Terho Lehtimäki; Markku Eskola; Ismo Anttila; Antti Jula; Antoni Bayés de Luna; Kjell Nikus; Jussi Hernesniemi
Journal:  Ann Med       Date:  2020-03-14       Impact factor: 4.709

2.  Advanced interatrial block is a surrogate for left atrial strain reduction which predicts atrial fibrillation and stroke.

Authors:  Juan Lacalzada-Almeida; María Manuela Izquierdo-Gómez; Javier García-Niebla; Roberto Elosua; Alejandro Jiménez-Sosa; Adrian Baranchuk; Antonio Bayes de Luna
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-05       Impact factor: 1.468

Review 3.  Second-degree interatrial block: Brief review and concept.

Authors:  Antonio Bayés de Luna; Adrián Baranchuk; César Niño Pulido; Manuel Martínez-Sellés; Antonio Bayés-Genís; Roberto Elosua; Marcelo V Elizari
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-02       Impact factor: 1.468

Review 4.  P Wave Parameters and Indices: A Critical Appraisal of Clinical Utility, Challenges, and Future Research-A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology.

Authors:  Lin Yee Chen; Antonio Luiz Pinho Ribeiro; Pyotr G Platonov; Iwona Cygankiewicz; Elsayed Z Soliman; Bulent Gorenek; Takanori Ikeda; Vassilios P Vassilikos; Jonathan S Steinberg; Niraj Varma; Antoni Bayés-de-Luna; Adrian Baranchuk
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.